Tag Archives: NASDAQ:RGLS

Wedbush Reiterates a Hold Rating on Regulus (RGLS)

In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Regulus (NASDAQ: RGLS), with a price target of $2.34. The company’s shares opened today at $2.38, close to its 52-week low of $2.03. According to TipRanks.com,

Regulus (RGLS) Gets a Hold Rating from B.Riley FBR

In a report released today, Madhu Kumar from B.Riley FBR reiterated a Hold rating on Regulus (NASDAQ: RGLS), with a price target of $0.25. The company’s shares opened today at $0.20, close to its 52-week low of $0.17. Kumar wrote:

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Regulus (NASDAQ: RGLS), Perrigo Company plc (NYSE: PRGO) and Spero Therapeutics Inc (NASDAQ: SPRO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Regulus (NASDAQ:RGLS), Perrigo Company plc (NYSE:PRGO) and Spero Therapeutics Inc (NASDAQ:SPRO). Regulus (RGLS) In a report released yesterday, Liana Moussatos from Wedbush reiterated

Regulus Gets a Hold Rating from Needham

Needham analyst Alan Carr assigned a Hold rating to Regulus (NASDAQ: RGLS) today. The company’s shares opened today at $0.90, close to its 52-week low of $0.79. Carr commented: “Regulus reported 3Q17 financial results last wk and we met w/

Analysts Offer Insights on Healthcare Companies: Regulus (NASDAQ: RGLS), Retrophin (NASDAQ: RTRX) and Glaukos (NYSE: GKOS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Regulus (NASDAQ: RGLS), Retrophin (NASDAQ: RTRX) and Glaukos (NYSE: GKOS). Regulus (NASDAQ: RGLS) BMO Capital analyst Matthew Luchini reiterated a Hold rating on

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Regulus (NASDAQ: RGLS) and Blueprint Medicines (NASDAQ: BPMC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regulus (NASDAQ: RGLS) and Blueprint Medicines (NASDAQ: BPMC). Regulus (NASDAQ: RGLS) Needham analyst Alan Carr reiterated a Hold rating on Regulus (NASDAQ: RGLS) today. The